PM360 2021 Trailblazer Awards Sales Aid Silver Winner Evoke Pharma and EVERSANA ENGAGE

Engaging Sales Collateral to Bring New Hope and Treatment for Patients with Diabetic Gastroparesis (Evoke Pharma, EVERSANA™ ENGAGE)

Diabetic gastroparesis is a condition that prevents food from breaking down and moving into the small intestine. It can cause vomiting, nausea, abdominal pain, and bloating, creating discomfort, embarrassment, and frustration for patients.

Startup Evoke Pharma partnered with EVERSANA ENGAGE to create a compelling campaign that demonstrated the clear benefits of Gimoti, the first nasal spray treatment of its kind. The “Spray Away” campaign educated patients and providers about the new treatment for diabetic gastroparesis. The campaign, anchored with the “mist” type canister, highlighted the major differentiation for the new therapy, and included both consumer-facing and clinician-facing websites and patient education brochures.

The “Spray Away” campaign has been successful. Since launch in October 2020, reps provided over 10,000 collateral pieces to healthcare offices across the U.S. The websites received more than 61,000 page views combined since launch and continue to see increased monthly traffic.

Ads

You May Also Like

ELITE 2019 Tech-Know Geek David Guthrie of PatientPoint

David Guthrie Chief Product Officer PatientPoint Innovating the Point of Care David Guthrie lives ...

PM360 2019 Innovative Division Valuate Health Consultancy of Omnicom Health Group

Valuate Health Consultancy Omnicom Health Group Dina Steinfurth, Managing Director dsteinfurth@valuatehealth.com Valuate Health Consultancy ...

PM360 2020 Innovative Product Veeva CRM Boost for Crossix DIFA from Veeva Crossix

Veeva CRM Boost for Crossix DIFA Veeva Crossix Jeff Davis, SVP, Business Development jeff.davis@veeva.com ...